Shopping Cart 0
Cart Subtotal
USD 0

Tissue Sealants - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 8000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 12000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Tissue Sealants-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Tissue Sealants-Medical Devices Pipeline Assessment, 2018" provides an overview of Tissue Sealants currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Sealants pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Tissue Sealants under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Tissue Sealants and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Tissue Sealants under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 8

2 Introduction 9

2.1 Tissue Sealants Overview 9

3 Products under Development 10

3.1 Tissue Sealants-Pipeline Products by Stage of Development 10

3.2 Tissue Sealants-Pipeline Products by Segment 11

3.3 Tissue Sealants-Pipeline Products by Territory 12

3.4 Tissue Sealants-Pipeline Products by Regulatory Path 13

3.5 Tissue Sealants-Pipeline Products by Estimated Approval Date 14

3.6 Tissue Sealants-Ongoing Clinical Trials 15

4 Tissue Sealants-Pipeline Products under Development by Companies 16

4.1 Tissue Sealants Companies-Pipeline Products by Stage of Development 16

4.2 Tissue Sealants-Pipeline Products by Stage of Development 18

5 Tissue Sealants Companies and Product Overview 20

5.1 Adhesys Medical GmbH Company Overview 20

5.2 Advanced Medical Solutions Group plc Company Overview 22

5.3 Aleo BME Inc Company Overview 23

5.4 Angiotech Pharmaceuticals Inc Company Overview 24

5.5 Baxter International Inc Company Overview 25

5.6 Biomedica Management Corp Company Overview 26

5.7 Boston University Company Overview 27

5.8 C. R. Bard Inc Company Overview 28

5.9 Calmare Therapeutics Inc Company Overview 30

5.10 Clemson University Company Overview 31

5.11 Cohera Medical Inc Company Overview 32

5.12 Covalent Medical, Inc. (Inactive) Company Overview 37

5.13 DSM Biomedical BV Company Overview 38

5.14 Elastagen Pty Ltd Company Overview 39

5.15 Ethicon Endo-Surgery Inc Company Overview 40

5.16 Gamma Therapeutics Inc Company Overview 41

5.17 GATT Technologies BV Company Overview 42

5.18 Gecko Biomedical Company Overview 44

5.19 Grifols SA Company Overview 45

5.20 Hemostasis LLC Company Overview 46

5.21 HyperBranch Medical Technology Inc Company Overview 47

5.22 Institute of Molecular Biology of Parana Company Overview 49

5.23 InVivo Therapeutics Corp Company Overview 50

5.24 Johns Hopkins University Company Overview 51

5.25 Kollodis BioSciences Inc Company Overview 52

5.26 Kuros Biosciences AG Company Overview 53

5.27 Laser Tissue Welding, Inc. Company Overview 55

5.28 LifeBond Ltd Company Overview 58

5.29 Medisse BV (Inactive) Company Overview 62

5.30 Pharming Group NV Company Overview 63

5.31 Polyganics BV Company Overview 64

5.32 Protein Polymer Technologies Inc (Inactive) Company Overview 67

5.33 Samyang Biopharmaceuticals Corp Company Overview 68

5.34 Sealantis Ltd. Company Overview 69

5.35 Shanghai Haohai Biological Technology Co Ltd Company Overview 71

5.36 Surgical Sealants, Inc. Company Overview 73

5.37 Teijin Pharma Ltd Company Overview 74

5.38 Texas A&M University Company Overview 75

5.39 The Medicines Company Overview 77

5.40 Tissue Regenix Ltd Company Overview 78

5.41 University of Akron Company Overview 79

6 Tissue Sealants- Recent Developments 80

6.1 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO 80

6.2 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals 80

6.3 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 81

6.4 Jun 04, 2018: Cesca Therapeutics Announces Reduction in Operating Expenses 82

6.5 May 31, 2018: Kuros Biosciences to Propose Appointment of New Board Members at AGM 82

6.6 May 25, 2018: Grifols culminates a year of growth and approves the distribution of a record EUR 265 million in dividends 83

6.7 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 84

6.8 May 23, 2018: Grifols publishes its 2017 Corporate Responsibility Report as part of its commitment to transparency 87

6.9 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference 87

6.10 May 14, 2018: Cesca Therapeutics Reports First Quarter 2018 Financial Results 89

6.11 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 90

6.12 May 03, 2018: Grifols increases its net profit by 7% to Euros 143 million and delivers significant growth in organic sales 91

6.13 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results 94

6.14 Apr 30, 2018: Kuros Biosciences Reports Full-Year 2017 Results 96

6.15 Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018 96

6.16 Apr 25, 2018: Cohera Medical Awarded Patent on its Biodegradable Sealant Technology 98

6.17 Apr 25, 2018: The Medicines Company Reports First-Quarter 2018 Results 99

6.18 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 100

6.19 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 102

6.20 Mar 27, 2018: The Medicines Company Announces Chief Financial Officer Transition 103

6.21 Mar 22, 2018: Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update 104

6.22 Mar 20, 2018: LiDCO Group: End of third party UK Distribution agreement 105

6.23 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 106

6.24 Mar 14, 2018: Advanced Medical Solutions Group: Unaudited Preliminary Results for the year ended 31 December 2017 107

6.25 Mar 08, 2018: FDA Grants Breakthrough Device Designation to Polyganics' Liver and Pancreas Sealant Patch 114

6.26 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 115

6.27 Feb 27, 2018: The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors 116

6.28 Feb 21, 2018: The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results 116

6.29 Feb 01, 2018: Grunenthal Group receives FDA's Expedited Access Pathway designation for VIVO 118

6.30 Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results 118

6.31 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 121

6.32 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results 122

6.33 Jan 19, 2018: Grunenthal Group receives CE-Certification for innovative surgical sealant 124

6.34 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience 125

6.35 Jan 04, 2018: Sealantis Receives CE Marking For Seal-G Surgical Sealant For GI Procedures 126

7 Appendix 181

7.1 Methodology 181

7.2 About GlobalData 184

7.3 Contact Us 184

7.4 Disclaimer 184


List Of Figure

1.2 List of Figures

Figure 1: Tissue Sealants-Pipeline Products by Stage of Development 11

Figure 2: Tissue Sealants-Pipeline Products by Segment 12

Figure 3: Tissue Sealants-Pipeline Products by Territory 13

Figure 4: Tissue Sealants-Pipeline Products by Regulatory Path 14

Figure 5: Tissue Sealants-Pipeline Products by Estimated Approval Date 15

Figure 6: Tissue Sealants-Ongoing Clinical Trials 16


List Of Table

1.1 List of Tables

Table 1: Tissue Sealants-Pipeline Products by Stage of Development 11

Table 2: Tissue Sealants-Pipeline Products by Segment 12

Table 3: Tissue Sealants-Pipeline Products by Territory 13

Table 4: Tissue Sealants-Pipeline Products by Regulatory Path 14

Table 5: Tissue Sealants-Pipeline Products by Estimated Approval Date 15

Table 6: Tissue Sealants-Ongoing Clinical Trials 16

Table 7: Tissue Sealants Companies-Pipeline Products by Stage of Development 17

Table 8: Tissue Sealants-Pipeline Products by Stage of Development 19

Table 9: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 21

Table 10: CUTIS-Product Status 21

Table 11: CUTIS-Product Description 21

Table 12: VIVO-Product Status 22

Table 13: VIVO-Product Description 22

Table 14: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 15: Next Generation Internal Fixation And Sealant Device-Product Status 23

Table 16: Next Generation Internal Fixation And Sealant Device-Product Description 23

Table 17: Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 18: Dural Sealant-Product Status 24

Table 19: Dural Sealant-Product Description 24

Table 20: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 21: Hemaseel HMN Fibrin Sealant-Product Status 25

Table 22: Hemaseel HMN Fibrin Sealant-Product Description 25

Table 23: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 24: Tisseel Dura-Product Status 26

Table 25: Tisseel Dura-Product Description 26

Table 26: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Table 27: ClotBlock-Product Status 27

Table 28: ClotBlock-Product Description 27

Table 29: Boston University Pipeline Products & Ongoing Clinical Trials Overview 28

Table 30: Hydrogel-based Aerosolized Sealant Dressing-Product Status 28

Table 31: Hydrogel-based Aerosolized Sealant Dressing-Product Description 28

Table 32: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 33: Progel Dural Sealant-Product Status 29

Table 34: Progel Dural Sealant-Product Description 29

Table 35: Progel Emerald-Product Status 30

Table 36: Progel Emerald-Product Description 30

Table 37: Tridyne Peripheral-Product Status 30

Table 38: Tridyne Peripheral-Product Description 30

Table 39: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 40: Wound Sealant-Product Status 31

Table 41: Wound Sealant-Product Description 31

Table 42: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 32

Table 43: Surgical Adhesive Hydrogel-Product Status 32

Table 44: Surgical Adhesive Hydrogel-Product Description 32

Table 45: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 46: Sylys Surgical Sealant-Product Status 33

Table 47: Sylys Surgical Sealant-Product Description 33

Table 48: Sylys Surgical Sealant-Drug Delivery-Product Status 34

Table 49: Sylys Surgical Sealant-Drug Delivery-Product Description 34

Table 50: Sylys Surgical Sealant-Hernia Mesh Fixation-Product Status 34

Table 51: Sylys Surgical Sealant-Hernia Mesh Fixation-Product Description 35

Table 52: Sylys Surgical Sealant-Orthopedic Procedures-Product Status 35

Table 53: Sylys Surgical Sealant-Orthopedic Procedures-Product Description 35

Table 54: Cohera Medical Inc-Ongoing Clinical Trials Overview 36

Table 55: Sylys Surgical Sealant-A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant 37

Table 56: Sylys Surgical Sealant-A Prospective, Randomized, Controlled, Multicenter Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant 37

Table 57: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

Table 58: Covabond-Product Status 38

Table 59: Covabond-Product Description 38

Table 60: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 39

Table 61: Dural Membrane Sealant-Product Status 39

Table 62: Dural Membrane Sealant-Product Description 39

Table 63: Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Table 64: MeTro-Surgical Glue-Product Status 40

Table 65: MeTro-Surgical Glue-Product Description 40

Table 66: Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Table 67: Bioseal Next Gen Device-Product Status 41

Table 68: Bioseal Next Gen Device-Product Description 41

Table 69: Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Table 70: GammaSeal-Product Status 42

Table 71: GammaSeal-Product Description 42

Table 72: GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview 43

Table 73: GATT-Spray-Product Status 43

Table 74: GATT-Spray-Product Description 43

Table 75: GATT-Tape-Product Status 44

Table 76: GATT-Tape-Product Description 44

Table 77: Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview 45

Table 78: SETALUM Sealant-Product Status 45

Table 79: SETALUM Sealant-Product Description 45

Table 80: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 46

Table 81: Fibrin Biological Glue-Product Status 46

Table 82: Fibrin Biological Glue-Product Description 46

Table 83: Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 47

Table 84: Advanced Tissue Sealant-Product Status 47

Table 85: Advanced Tissue Sealant-Product Description 47

Table 86: HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Table 87: Adherus Vascular Sealant-Product Status 48

Table 88: Adherus Vascular Sealant-Product Description 48

Table 89: Tissue Plane Sealant-Product Status 49

Table 90: Tissue Plane Sealant-Product Description 49

Table 91: Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 50

Table 92: Recombinant Fibrin Glue-Product Status 50

Table 93: Recombinant Fibrin Glue-Product Description 50

Table 94: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 51

Table 95: InVivoSeal-Product Status 51

Table 96: InVivoSeal-Product Description 51

Table 97: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 52

Table 98: Chondroitin Sulfate-based Adhesive-Product Status 52

Table 99: Chondroitin Sulfate-based Adhesive-Product Description 52

Table 100: Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Table 101: Hemostat Sealant-Product Status 53

Table 102: Hemostat Sealant-Product Description 53

Table 103: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 54

Table 104: KUR-211-Product Status 54

Table 105: KUR-211-Product Description 54

Table 106: KUR-212-Product Status 55

Table 107: KUR-212-Product Description 55

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Adhesys Medical GmbH

Advanced Medical Solutions Group plc

Aleo BME Inc

Angiotech Pharmaceuticals Inc

Baxter International Inc

Biomedica Management Corp

Boston University

C. R. Bard Inc

Calmare Therapeutics Inc

Clemson University

Cohera Medical Inc

Covalent Medical, Inc.

DSM Biomedical BV

Elastagen Pty Ltd

Ethicon Endo-Surgery Inc

Gamma Therapeutics Inc

GATT Technologies BV

Gecko Biomedical

Grifols SA

Hemostasis LLC

HyperBranch Medical Technology Inc

Institute of Molecular Biology of Parana

InVivo Therapeutics Corp

Johns Hopkins University

Kollodis BioSciences Inc

Kuros Biosciences AG

Laser Tissue Welding, Inc.

LifeBond Ltd

Medisse BV

Pharming Group NV

Polyganics BV

Protein Polymer Technologies Inc

Samyang Biopharmaceuticals Corp

Sealantis Ltd.

Shanghai Haohai Biological Technology Co Ltd

Surgical Sealants, Inc.

Teijin Pharma Ltd

Texas A&M University

The Medicines

Tissue Regenix Ltd

University of Akron